Pfizer, BioNTech submit omicron booster for FDA clearance

Pfizer and partner BioNTech have officially asked the Food and Drug Administration for emergency clearance of a omicron variant-adapted booster shot, announcing Monday they’ve completed submission of their application to the regulator.